Edwards Lifesciences share price today

(EW)

Edwards Lifesciences share price is $74.81 & ₹6,357.05 as on 21 Dec 2024, 2.30 'hrs' IST

$74.81

▲

0.88

(1.19%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Edwards Lifesciences share price in Dollar and Rupees. Guide to invest in Edwards Lifesciences from India. Also see the sentimental analysis on Indian investors investing in Edwards Lifesciences. Get details on the Indian mutual funds that are investing in Edwards Lifesciences. Get Analyst recommendations and forecasts along with all the Edwards Lifesciences's financials.

Edwards Lifesciences share price movements

Today's Low: $73.00
Today's High: $75.25
$74.81
2.43%
Downside
Day's Volatility :3.0%
Upside
0.58%
52 Weeks Low: $58.93
52 Weeks High: $96.12
$74.81
21.23%
Downside
52 Weeks Volatility :38.69%
Upside
22.17%

Edwards Lifesciences Returns

Period	Edwards Lifesciences Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	11.06%	-11.1%	0.0%
6 Months	-17.03%	-6.0%	0.0%
1 Year	-1.93%	2.2%	0.0%
3 Years	-41.81%	-0.5%	-20.4%

Edwards Lifesciences Key Statistics

in dollars & INR

Previous Close	$73.93
Open	$73.3
Today's High	$75.25
Today's Low	$72.995
Market Capitalization	$44.1B
Today's Volume	$13.3M
52 Week High	$96.12
52 Week Low	$58.93
Revenue TTM	$6.3B
EBITDA	$2.1B
Earnings Per Share (EPS)	$2.59
PE Ratio	28.88
Profit Margin	65.86%
Quarterly Earnings Growth YOY	7.16%
Return On Equity TTM	19.14%

How to invest in Edwards Lifesciences from India?

It is very easy for Indian residents to invest directly in Edwards Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Edwards Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Edwards Lifesciences or EW on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Edwards Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Edwards Lifesciences shares which would translate to 0.011 fractional shares of Edwards Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Edwards Lifesciences, in just a few clicks!

Returns in Edwards Lifesciences for Indian investors in Rupees

Investment Value

₹1,00,000

Edwards Lifesciences investment value today

Current value as on today

₹1,04,123

Returns

₹4,123

(+4.12%)

Returns from Edwards Lifesciences Stock

₹1,927 (false-1.93%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Edwards Lifesciences

-6%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Edwards Lifesciences on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -6% less investors are searching Edwards Lifesciences in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Edwards Lifesciences

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	5177	0.10	0.08%

Global Institutional Holdings in Edwards Lifesciences

Vanguard Group Inc
10.61%
BlackRock Inc
8.64%
Wellington Management Company LLP
5.35%
State Street Corp
4.45%
Bank of New York Mellon Corp
3.10%
Geode Capital Management, LLC
2.29%

Analyst Recommendation on Edwards Lifesciences

Buy

60%Buy

35%Hold

5%Sell

Based on 40 Wall street analysts offering stock ratings for Edwards Lifesciences(by analysts ranked 0 to 5 stars)

Based on 40 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Edwards Lifesciences

What analysts predicted

Upside of 6.0%

Current:

$74.81

Target:

$79.30

Insights on Edwards Lifesciences

Price Movement
In the last 7 days, EW stock has moved up by 2.0%
Decreasing Revenue
Edwards Lifesciences Corp. has experienced a decline in revenue for the last three quarters. Revenue decreased from $1.59 billion to $1.35 billion, reflecting an average decrease of 7.8% per quarter.
Increasing Net Profit
Edwards Lifesciences Corp. has shown strong profit growth over the last three quarters. Their net profit increased from $351.9 million to $3.07 billion, which is an average rise of 46.0% each quarter.
EW vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 59.1% return, outperforming this stock by 60.4%
EW vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 111.0% return, outperforming this stock by 152.5%
Price to Sales
Edwards Lifesciences Corp. has a Price-to-Sales Ratio of 7.1, meaning that investors are willing to pay $7.1 for every $1 of sales the company generates. In comparison, investors are willing to pay $8.2 for every $1 of sales for Boston Scientific Corp. This indicates that Edwards Lifesciences is valued slightly lower by investors in terms of its sales performance compared to Boston Scientific.

Edwards Lifesciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.7B	↑ 8.37%
Net Income	$722.2M	↑ 16.09%
Net Profit Margin	19.4%	↑ 1.29%

	FY19	Y/Y Change
Revenue	$4.3B	↑ 16.79%
Net Income	$1.0B	↑ 44.96%
Net Profit Margin	24.08%	↑ 4.68%

	FY20	Y/Y Change
Revenue	$4.4B	↑ 0.88%
Net Income	$823.4M	↓ 21.35%
Net Profit Margin	18.77%	↓ 5.31%

	FY21	Y/Y Change
Revenue	$5.2B	↑ 19.29%
Net Income	$1.5B	↑ 82.55%
Net Profit Margin	28.73%	↑ 9.96%

	FY22	Y/Y Change
Revenue	$5.4B	↑ 2.86%
Net Income	$1.5B	↑ 1.25%
Net Profit Margin	28.28%	↓ 0.45%

	FY23	Y/Y Change
Revenue	$6.0B	↑ 11.56%
Net Income	$1.4B	↓ 7.85%
Net Profit Margin	23.35%	↓ 4.93%

	Q2 FY23	Q/Q Change
Revenue	$1.5B	↑ 4.84%
Net Income	$307.1M	↓ 9.81%
Net Profit Margin	20.07%	↓ 3.26%

	Q3 FY23	Q/Q Change
Revenue	$1.5B	↓ 3.22%
Net Income	$384.9M	↑ 25.33%
Net Profit Margin	25.99%	↑ 5.92%

	Q4 FY23	Q/Q Change
Revenue	$1.5B	↑ 3.59%
Net Income	$369.9M	↓ 3.9%
Net Profit Margin	24.11%	↓ 1.88%

	Q1 FY24	Q/Q Change
Revenue	$1.6B	↑ 4.18%
Net Income	$351.9M	↓ 4.87%
Net Profit Margin	22.02%	↓ 2.09%

	Q2 FY24	Q/Q Change
Revenue	$1.4B	↓ 13.28%
Net Income	$366.3M	↑ 4.09%
Net Profit Margin	26.43%	↑ 4.41%

	Q3 FY24	Q/Q Change
Revenue	$1.4B	↓ 2.27%
Net Income	$3.1B	↑ 738.33%
Net Profit Margin	226.73%	↑ 200.3%

	FY18	Y/Y Change
Profit	$2.8B	↑ 8.73%

	FY19	Y/Y Change
Profit	$3.2B	↑ 16.17%

	FY20	Y/Y Change
Profit	$3.3B	↑ 2.23%

	FY21	Y/Y Change
Profit	$4.0B	↑ 20.51%

	FY22	Y/Y Change
Profit	$4.3B	↑ 7.99%

	FY23	Y/Y Change
Profit	$4.6B	↑ 7.51%

	Q2 FY23	Q/Q Change
Profit	$1.2B	↑ 5.05%

	Q3 FY23	Q/Q Change
Profit	$1.1B	↓ 4.78%

	Q4 FY23	Q/Q Change
Profit	$1.2B	↑ 4.13%

	Q1 FY24	Q/Q Change
Profit	$1.2B	↑ 3.13%

	Q2 FY24	Q/Q Change
Profit	$1.1B	↓ 10.37%

	Q3 FY24	Q/Q Change
Profit	$1.1B	↑ 0.31%

	FY18	Y/Y Change
Operating Cash Flow	$926.8M	↓ 7.38%
Investing Cash Flow	$76.7M	↓ 111.85%
Financing Cash Flow	$-1.1B	↑ 132.71%

	FY19	Y/Y Change
Operating Cash Flow	$1.2B	↑ 27.26%
Investing Cash Flow	$-595.8M	↓ 876.79%
Financing Cash Flow	$-115.6M	↓ 89.5%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↓ 10.61%
Investing Cash Flow	$-531.1M	↓ 10.86%
Financing Cash Flow	$-486.9M	↑ 321.19%

	FY21	Y/Y Change
Operating Cash Flow	$1.7B	↑ 64.29%
Investing Cash Flow	$-1.7B	↑ 224.33%
Financing Cash Flow	$-356.3M	↓ 26.82%

	FY22	Y/Y Change
Operating Cash Flow	$1.2B	↓ 29.67%
Investing Cash Flow	$252.3M	↓ 114.65%
Financing Cash Flow	$-1.6B	↑ 344.71%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$33.6M	↓ 89.3%
Investing Cash Flow	$70.2M	↑ 13940.0%
Financing Cash Flow	$52.1M	↓ 125.22%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$411.5M	↑ 1124.7%
Investing Cash Flow	$159.7M	↑ 127.49%
Financing Cash Flow	$-143.3M	↓ 375.05%

Edwards Lifesciences Technicals Summary

Sell

Neutral

Buy

Edwards Lifesciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Edwards Lifesciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.93%	-41.81%	-4.82%
Stryker Corporation	-6.55%	7.53%	21.91%	35.92%	72.32%
Boston Scientific Corp.	-2.79%	15.96%	58.87%	108.22%	96.31%
Abbott Laboratories	-2.58%	8.48%	4.58%	-17.91%	30.88%
Medtronic Plc	-4.38%	-0.01%	-1.54%	-21.25%	-28.78%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Edwards Lifesciences Corp.	Buy	$44.1B	-4.82%	28.88	65.86%
Stryker Corporation	Buy	$136.1B	72.32%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.31%	73.27	11.26%
Abbott Laboratories	Buy	$195.0B	30.88%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.78%	24.46	12.06%

About Edwards Lifesciences

edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.

Organization	Edwards Lifesciences
Employees	19800
CEO	Mr. Bernard J. Zovighian
Industry	Health Technology

Management People of Edwards Lifesciences

Name	Title
Mr. Bernard J. Zovighian	CEO & Director
Mr. Scott B. Ullem	Corporate VP & CFO
Mr. Donald E. Bobo Jr.	Corporate Vice President of Strategy & Corporate Development
Mr. Larry L. Wood	Corporate VP and Group President of TAVR & Surgical Structural Heart
Mr. Andrew M. Dahl	Principal Accounting Officer, Senior VP & Corporate Controller
Dr. Todd J. Brinton FACC, M.D.	Corporate VP of Advanced Technology & Chief Scientific Officer
Mr. Mark Wilterding	Vice President of Investor Relations
Mr. Arnold A. Pinkston J.D.	Corporate VP & General Counsel
Mr. Dirksen J. Lehman	Corporate Vice President of Public Affairs
Ms. Christine Z. McCauley	Corporate Vice President of Human Resources

Important FAQs about investing in Edwards Lifesciences from India :

What is Edwards Lifesciences share price today?

Edwards Lifesciences share price today stands at $74.81, Open: $73.30 ; Previous Close: $73.93 ; High: $75.25 ; Low: $73.00 ; 52 Week High: $96.12 ; 52 Week Low: $58.93. The stock opens at $73.30, after a previous close of $73.93. The stock reached a daily high of $75.25 and a low of $73.00, with a 52-week high of $96.12 and a 52-week low of $58.93.

Can Indians buy Edwards Lifesciences shares?

Yes, Indians can invest in the Edwards Lifesciences (EW) from India.

With INDmoney, you can buy Edwards Lifesciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Edwards Lifesciences at zero transaction cost.

How can I buy Edwards Lifesciences shares from India?

It is very easy to buy Edwards Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Edwards Lifesciences be purchased?

Yes, you can buy fractional shares of Edwards Lifesciences with INDmoney app.

What are the documents required to start investing in Edwards Lifesciences stocks?

To start investing in Edwards Lifesciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.